Loading…

Power morcellators: a review of current practice and assessment of risk

Power morcellation has come under scrutiny because of a highly publicized case of disseminated leiomyosarcoma following a laparoscopic hysterectomy. A recent Federal and Drug Administration safety communication discouraging use of power morcellators on presumed uterine leiomyoma further highlights t...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of obstetrics and gynecology 2015-01, Vol.212 (1), p.18-23
Main Authors:	Senapati, Sangeeta, MD, MS, Tu, Frank F., MD MPH, Magrina, Javier F., MD
Format:	Article
Language:	English
Subjects:	Female Humans hysterectomy Hysterectomy - adverse effects Hysterectomy - instrumentation Hysterectomy - methods leiomyoma Leiomyoma - surgery morcellation myomectomy Obstetrics and Gynecology Practice Patterns, Physicians Risk Assessment uterine malignancy Uterine Neoplasms - surgery
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c547t-c3cbe14f1abe4b8c5888890170af814a5a7ef159eb828193c15496e3860ae6583
cites	cdi_FETCH-LOGICAL-c547t-c3cbe14f1abe4b8c5888890170af814a5a7ef159eb828193c15496e3860ae6583
container_end_page	23
container_issue	1
container_start_page	18
container_title	American journal of obstetrics and gynecology
container_volume	212
creator	Senapati, Sangeeta, MD, MS Tu, Frank F., MD MPH Magrina, Javier F., MD
description	Power morcellation has come under scrutiny because of a highly publicized case of disseminated leiomyosarcoma following a laparoscopic hysterectomy. A recent Federal and Drug Administration safety communication discouraging use of power morcellators on presumed uterine leiomyoma further highlights the need for reexamination of uterine tissue extraction. This clinical opinion aims to summarize current approaches to uterine/fibroid tissue extraction including the associated immediate and long-term potential risks of open power morcellation. The known data about risk of uterine sarcoma is reviewed followed by a discussion of acceptable risk and informed consent in the context of shared-decision making.
doi_str_mv	10.1016/j.ajog.2014.07.046
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1639983957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937814007959</els_id><sourcerecordid>1639983957</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-c3cbe14f1abe4b8c5888890170af814a5a7ef159eb828193c15496e3860ae6583</originalsourceid><addsrcrecordid>eNp9kVFL3TAYhoNszDO3P-DF6OVu2n1JmiaRMRBxThAm6K5DmvN1pLbNWdIq_nvTHd3FLsxNSHjel-T5CDmmUFGgzZe-sn34XTGgdQWygro5IBsKWpaNatQbsgEAVmou1SF5n1K_Hplm78ghEyCZ5HJDLq7DA8ZiDNHhMNg5xHRS2CLivceHInSFW2LEaS520brZOyzstC1sSpjSuN5nJPp094G87eyQ8OPzfkR-fT-_PftRXv28uDw7vSqdqOVcOu5apHVHbYt1q5xQeWmgEmynaG2FldhRobFVTFHNHRW1bpCrBiw2QvEj8nnfu4vhz4JpNqNPf58-YViSoQ3XWnEtZEbZHnUxpBSxM7voRxsfDQWzCjS9WQWaVaABabLAHPr03L-0I27_RV6MZeDrHsD8yywpmuQ8Tg63PqKbzTb41_u__Rd3g5-8s8MdPmLqwxKn7M9Qk5gBc7PObJ0grQGkFpo_Ab0cldo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1639983957</pqid></control><display><type>article</type><title>Power morcellators: a review of current practice and assessment of risk</title><source>ScienceDirect Journals</source><creator>Senapati, Sangeeta, MD, MS ; Tu, Frank F., MD MPH ; Magrina, Javier F., MD</creator><creatorcontrib>Senapati, Sangeeta, MD, MS ; Tu, Frank F., MD MPH ; Magrina, Javier F., MD</creatorcontrib><description>Power morcellation has come under scrutiny because of a highly publicized case of disseminated leiomyosarcoma following a laparoscopic hysterectomy. A recent Federal and Drug Administration safety communication discouraging use of power morcellators on presumed uterine leiomyoma further highlights the need for reexamination of uterine tissue extraction. This clinical opinion aims to summarize current approaches to uterine/fibroid tissue extraction including the associated immediate and long-term potential risks of open power morcellation. The known data about risk of uterine sarcoma is reviewed followed by a discussion of acceptable risk and informed consent in the context of shared-decision making.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2014.07.046</identifier><identifier>PMID: 25072737</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Female ; Humans ; hysterectomy ; Hysterectomy - adverse effects ; Hysterectomy - instrumentation ; Hysterectomy - methods ; leiomyoma ; Leiomyoma - surgery ; morcellation ; myomectomy ; Obstetrics and Gynecology ; Practice Patterns, Physicians ; Risk Assessment ; uterine malignancy ; Uterine Neoplasms - surgery</subject><ispartof>American journal of obstetrics and gynecology, 2015-01, Vol.212 (1), p.18-23</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-c3cbe14f1abe4b8c5888890170af814a5a7ef159eb828193c15496e3860ae6583</citedby><cites>FETCH-LOGICAL-c547t-c3cbe14f1abe4b8c5888890170af814a5a7ef159eb828193c15496e3860ae6583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25072737$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Senapati, Sangeeta, MD, MS</creatorcontrib><creatorcontrib>Tu, Frank F., MD MPH</creatorcontrib><creatorcontrib>Magrina, Javier F., MD</creatorcontrib><title>Power morcellators: a review of current practice and assessment of risk</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Power morcellation has come under scrutiny because of a highly publicized case of disseminated leiomyosarcoma following a laparoscopic hysterectomy. A recent Federal and Drug Administration safety communication discouraging use of power morcellators on presumed uterine leiomyoma further highlights the need for reexamination of uterine tissue extraction. This clinical opinion aims to summarize current approaches to uterine/fibroid tissue extraction including the associated immediate and long-term potential risks of open power morcellation. The known data about risk of uterine sarcoma is reviewed followed by a discussion of acceptable risk and informed consent in the context of shared-decision making.</description><subject>Female</subject><subject>Humans</subject><subject>hysterectomy</subject><subject>Hysterectomy - adverse effects</subject><subject>Hysterectomy - instrumentation</subject><subject>Hysterectomy - methods</subject><subject>leiomyoma</subject><subject>Leiomyoma - surgery</subject><subject>morcellation</subject><subject>myomectomy</subject><subject>Obstetrics and Gynecology</subject><subject>Practice Patterns, Physicians</subject><subject>Risk Assessment</subject><subject>uterine malignancy</subject><subject>Uterine Neoplasms - surgery</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kVFL3TAYhoNszDO3P-DF6OVu2n1JmiaRMRBxThAm6K5DmvN1pLbNWdIq_nvTHd3FLsxNSHjel-T5CDmmUFGgzZe-sn34XTGgdQWygro5IBsKWpaNatQbsgEAVmou1SF5n1K_Hplm78ghEyCZ5HJDLq7DA8ZiDNHhMNg5xHRS2CLivceHInSFW2LEaS520brZOyzstC1sSpjSuN5nJPp094G87eyQ8OPzfkR-fT-_PftRXv28uDw7vSqdqOVcOu5apHVHbYt1q5xQeWmgEmynaG2FldhRobFVTFHNHRW1bpCrBiw2QvEj8nnfu4vhz4JpNqNPf58-YViSoQ3XWnEtZEbZHnUxpBSxM7voRxsfDQWzCjS9WQWaVaABabLAHPr03L-0I27_RV6MZeDrHsD8yywpmuQ8Tg63PqKbzTb41_u__Rd3g5-8s8MdPmLqwxKn7M9Qk5gBc7PObJ0grQGkFpo_Ab0cldo</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Senapati, Sangeeta, MD, MS</creator><creator>Tu, Frank F., MD MPH</creator><creator>Magrina, Javier F., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150101</creationdate><title>Power morcellators: a review of current practice and assessment of risk</title><author>Senapati, Sangeeta, MD, MS ; Tu, Frank F., MD MPH ; Magrina, Javier F., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-c3cbe14f1abe4b8c5888890170af814a5a7ef159eb828193c15496e3860ae6583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Female</topic><topic>Humans</topic><topic>hysterectomy</topic><topic>Hysterectomy - adverse effects</topic><topic>Hysterectomy - instrumentation</topic><topic>Hysterectomy - methods</topic><topic>leiomyoma</topic><topic>Leiomyoma - surgery</topic><topic>morcellation</topic><topic>myomectomy</topic><topic>Obstetrics and Gynecology</topic><topic>Practice Patterns, Physicians</topic><topic>Risk Assessment</topic><topic>uterine malignancy</topic><topic>Uterine Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Senapati, Sangeeta, MD, MS</creatorcontrib><creatorcontrib>Tu, Frank F., MD MPH</creatorcontrib><creatorcontrib>Magrina, Javier F., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Senapati, Sangeeta, MD, MS</au><au>Tu, Frank F., MD MPH</au><au>Magrina, Javier F., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Power morcellators: a review of current practice and assessment of risk</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>212</volume><issue>1</issue><spage>18</spage><epage>23</epage><pages>18-23</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><abstract>Power morcellation has come under scrutiny because of a highly publicized case of disseminated leiomyosarcoma following a laparoscopic hysterectomy. A recent Federal and Drug Administration safety communication discouraging use of power morcellators on presumed uterine leiomyoma further highlights the need for reexamination of uterine tissue extraction. This clinical opinion aims to summarize current approaches to uterine/fibroid tissue extraction including the associated immediate and long-term potential risks of open power morcellation. The known data about risk of uterine sarcoma is reviewed followed by a discussion of acceptable risk and informed consent in the context of shared-decision making.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25072737</pmid><doi>10.1016/j.ajog.2014.07.046</doi><tpages>6</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0002-9378
ispartof	American journal of obstetrics and gynecology, 2015-01, Vol.212 (1), p.18-23
issn	0002-9378 1097-6868
language	eng
recordid	cdi_proquest_miscellaneous_1639983957
source	ScienceDirect Journals
subjects	Female Humans hysterectomy Hysterectomy - adverse effects Hysterectomy - instrumentation Hysterectomy - methods leiomyoma Leiomyoma - surgery morcellation myomectomy Obstetrics and Gynecology Practice Patterns, Physicians Risk Assessment uterine malignancy Uterine Neoplasms - surgery
title	Power morcellators: a review of current practice and assessment of risk
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T18%3A49%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Power%20morcellators:%20a%20review%20of%20current%20practice%20and%20assessment%20of%20risk&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Senapati,%20Sangeeta,%20MD,%20MS&rft.date=2015-01-01&rft.volume=212&rft.issue=1&rft.spage=18&rft.epage=23&rft.pages=18-23&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/j.ajog.2014.07.046&rft_dat=%3Cproquest_cross%3E1639983957%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c547t-c3cbe14f1abe4b8c5888890170af814a5a7ef159eb828193c15496e3860ae6583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1639983957&rft_id=info:pmid/25072737&rfr_iscdi=true